Clinical Study for the Effectiveness of Roflumilast Treatment in COPD Greek Patients Based on Standard Clinical Practice.
Clinical trial NCT05426915 · UNKNOWN
Trial details
- NCT number
- NCT05426915
- Sponsor
- Elpen Pharmaceutical Co. Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-01
- Primary completion
- 2024-05-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.